Stock Scorecard



Stock Summary for Pacific Biosciences of California Inc (PACB) - $3.75 as of 3/28/2024 8:25:01 PM EST

Total Score

11 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for PACB

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for PACB

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for PACB

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for PACB

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for PACB

Pacific Biosciences of California ( NASDAQ:PACB ) Stock Rating Upgraded by StockNews.com 3/20/2024 7:30:00 AM
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March - Inspire Veterinary ( NASDAQ:IVP ) , Fractyl Health ( NASDAQ:GUTS ) 3/19/2024 12:08:00 PM
PacBio's ( PACB ) New Panel to Aid Its Clinical Research Solution 3/13/2024 2:17:00 PM
Pacific Biosciences of California ( NASDAQ:PACB ) Upgraded to Sell at StockNews.com 3/12/2024 8:30:00 AM
Pacific Biosciences of California ( NASDAQ:PACB ) Lifted to Sell at StockNews.com 3/12/2024 8:28:00 AM
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March - Ironwood Pharmaceuticals ( NASDAQ:IRWD ) , Integra Lifesciences ( NASDAQ:IART ) 3/7/2024 12:18:00 PM
Epigenetics Market Research Report 2023-2030: DNA Methylation and Oncology Applications At the Forefront of Advancements 3/1/2024 7:45:00 PM
PacBio ( PACB ) Q4 Earnings Beat, Adjusted Gross Margin Down 2/16/2024 3:50:00 PM
Pacific Biosciences of California ( PACB ) Reports Q4 Loss, Tops Revenue Estimates 2/15/2024 10:30:00 PM
Medical Products Stocks' Earnings Due on Feb 15: WST, ITGR & More 2/14/2024 1:56:00 PM

Financial Details for PACB

Company Overview

Ticker PACB
Company Name Pacific Biosciences of California Inc
Country USA
Description Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to solve genetically complex problems. The company is headquartered in Menlo Park, California.
Sector Name LIFE SCIENCES
Industry Name LABORATORY ANALYTICAL INSTRUMENTS
Most Recent Quarter 12/31/2023
Next Earnings Date 4/30/2024

Stock Price History

Last Day Price 3.75
Last Day Price Updated 3/28/2024 8:25:01 PM EST
Last Day Volume 6,544,017
Average Daily Volume 8,866,166
52-Week High 14.55
52-Week Low 3.46
Last Price to 52 Week Low 8.38%

Valuation Measures

Trailing PE N/A
Industry PE 31.04
Sector PE 60.76
5-Year Average PE -47.66
Free Cash Flow Ratio 1.59
Industry Free Cash Flow Ratio 110.82
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 7.81
Total Cash Per Share 2.36
Book Value Per Share Most Recent Quarter 2.62
Price to Book Ratio 1.38
Industry Price to Book Ratio 802.29
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 4.82
Industry Price to Sales Ratio Twelve Trailing Months 4.25
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 267,952,000
Market Capitalization 1,004,820,000
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 2.39%
Reported EPS 12 Trailing Months -1.21
Reported EPS Past Year -1.21
Reported EPS Prior Year -1.40
Net Income Twelve Trailing Months -306,735,000
Net Income Past Year -306,735,000
Net Income Prior Year -314,248,000
Quarterly Revenue Growth YOY 113.30%
5-Year Revenue Growth 5.29%

Balance Sheet

Total Cash Most Recent Quarter 631,416,000
Total Cash Past Year 631,416,000
Total Cash Prior Year 772,318,000
Net Cash Position Most Recent Quarter 630,916,000
Net Cash Position Past Year 630,916,000
Long Term Debt Past Year 500,000
Long Term Debt Prior Year 896,683,000
Total Debt Most Recent Quarter 500,000
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 701,304,000
Total Stockholder Equity Prior Year 562,904,000
Total Stockholder Equity Most Recent Quarter 701,304,000

Options

Put/Call Ratio 0.24
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.65
MACD Signal -0.64
20-Day Bollinger Lower Band 3.19
20-Day Bollinger Middle Band 7.07
20-Day Bollinger Upper Band 10.96
Beta 1.87
RSI 33.47
50-Day SMA 9.57
200-Day SMA 14.51

System

Modified 3/27/2024 3:47:14 AM EST